💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…
Profile for Halozyme Therapeutics, Inc. (HALO)
« Back to company indexHALO Chatter Timeline
Stock Ticker for HALO
Most Active Tweeters for HALO
| User | Tweets |
|---|---|
| @Tickeron | 13 |
| @mediasentiment | 9 |
| @stockmktgenius | 6 |
| @stocknewstimes | 6 |
| @TranscriptDaily | 5 |
Recent Tweets for HALO
 |
@Tickeron $HALO's price moved above its 50-day Moving Average on October 8, 2020. View odds for this and other indicators:… https://t.co/lU1HhB0XWP October 25th 2020, 12:10pm |
|
@Tickeron $HALO's price moved above its 50-day Moving Average on October 8, 2020. View odds for this and other indicators:… https://t.co/sKjhxNNvcf October 24th 2020, 12:10pm |
 |
@HealthcareBeat Halozyme To Host THIRD Quarter 2020 Financial Results webcast and Conference Call $HALO https://t.co/bhkl4wfRrB October 24th 2020, 9:10am |
 |
@MarcJacksonLA $HALO $ARGX Halozyme Therapeutics And Argenx Expand Their Partnership And License Deal For ENHANZE® Technology… https://t.co/QBlrzfz4Om October 23rd 2020, 7:10pm |
 |
@LCOptionTrading $HALO above 30 is bullish $MTCH above 120 then 123 October 23rd 2020, 3:10pm |
|
@Tickeron $HALO's price moved above its 50-day Moving Average on October 8, 2020. View odds for this and other indicators:… https://t.co/AP9yMg72Ro October 23rd 2020, 2:10pm |
 |
@gcassidy718 $HALO buyer at $34.20 3.43 % change recently https://t.co/HafkoOqNbV October 23rd 2020, 10:10am |
 |
@Biotech2050 #2 another new argnx trial using $HALO rHuPH20 A Study to Assess the Efficacy and Safety of a Subcutaneous Formula… https://t.co/AgVHV5fJ57 October 23rd 2020, 9:10am |
|
@Biotech2050 #1 new study by argnx using $HALO rHuPH20 A Study to Assess the Long-term Safety and Efficacy of a Subcutaneous F… https://t.co/gBJfuhhDFx October 23rd 2020, 9:10am |
|
@gcassidy718 $HALO I’ll probably buy on the dip. Still need to do more research. 3.43 % https://t.co/HafkoOqNbV October 23rd 2020, 5:10am |
 |
@mediasentiment $HALO new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 242 October 23rd 2020, 5:10am |
 |
@stockmktgenius $HALO Halozyme Therapeutics, In Top stock up 124% from low. Close: 31.09 VolvsAvg: 1.23 Liq: $59M https://t.co/FjSu9UyEgs October 23rd 2020, 12:10am |
 |
@Jon12508683 $halo nice monthly candle. October 22nd 2020, 10:10pm |
|
@Tickeron $HALO's price moved above its 50-day Moving Average on October 8, 2020. View odds for this and other indicators:… https://t.co/kWKZzrvkn2 October 22nd 2020, 12:10pm |
|
@Biotech2050 $ATNM will surely become the next $HALO. Making available the platform to big pharma for a royalty if the coformula… https://t.co/0uZQRgmhsw October 22nd 2020, 9:10am |
 |
@ZolmaxNews Halozyme Therapeutics Sees Unusually Large Options Volume $HALO https://t.co/D7D5JPQ4p0 October 22nd 2020, 8:10am |
 |
@iamtito_ $HALO - Halozyme To Host THIRD Quarter 2020 Financial Results webcast and Conference Call https://t.co/ex14m5WA8k October 22nd 2020, 8:10am |
 |
@VisualStockRSRC $HALO - Halozyme To Host THIRD Quarter 2020 Financial Results webcast and Conference Call https://t.co/1CpCuXIm6Y October 22nd 2020, 8:10am |
 |
@Allstocknews $HALO Halozyme - Halozyme To Host THIRD Quarter 2020 Financial Results webcast and Conference Call From our Stock News Alerts App October 22nd 2020, 8:10am |
 |
@stock_titan $HALO Halozyme To Host THIRD Quarter 2020 Financial Results webcast and Conference Call https://t.co/aTQQgjSC0X October 22nd 2020, 8:10am |
 |
@portefeuillefun $ARGX $HALO. #argenx Reports Third Quarter 2020 Financial Results and Provides Business Update https://t.co/BsKaJpxs36. #efgartigimod October 22nd 2020, 4:10am |
 |
@BlueBioNow $HALO buyer at $33.24 2.58 % change recently https://t.co/LjL9I5Bf5v October 22nd 2020, 12:10am |
|
@stockmktgenius $HALO Halozyme Therapeutics, In Top stock up 117% from low. Close: 30.06 VolvsAvg: 1.23 Liq: $54M https://t.co/FjSu9UyEgs October 21st 2020, 9:10pm |
 |
@junglejava1 Halo Announces Results of Annual General Meeting $HALO https://t.co/Pdf8cWUETq October 21st 2020, 6:10pm |
 |
@WeekHerald Halozyme Therapeutics, Inc. $HALO Given Average Rating of “Buy” by Analysts https://t.co/KrRRa8jLep October 21st 2020, 3:10pm |
 |
@OlympiaReport Brokerages Set Halozyme Therapeutics, Inc. $HALO PT at $32.00 https://t.co/kXJA09ur0f October 21st 2020, 3:10pm |
|
@Tickeron $HALO's price moved above its 50-day Moving Average on October 8, 2020. View odds for this and other indicators:… https://t.co/YDBmyZ7paA October 21st 2020, 2:10pm |
 |
@TheMarketsDaily Analysts Expect Halozyme Therapeutics, Inc. $HALO to Announce $0.20 EPS https://t.co/xcCE7tGaP3 October 21st 2020, 11:10am |
 |
@stocknewstimes $0.20 Earnings Per Share Expected for Halozyme Therapeutics, Inc. $HALO This Quarter https://t.co/hTopPK4usF October 21st 2020, 11:10am |
 |
@AmericanBanking Analysts Expect Halozyme Therapeutics, Inc. $HALO to Announce $0.20 EPS https://t.co/oDgr66z3bi #stocks October 21st 2020, 11:10am |
 |
@TranscriptDaily Analysts Expect Halozyme Therapeutics, Inc. $HALO to Announce $0.20 EPS https://t.co/N3dnou6rAo October 21st 2020, 11:10am |
 |
@Boldieman RT @HaloMeetup: #darkmode ? how these icons pop! We are getting excited for #beta next month! #halo $HALO https://t.co/IfqbnU0xkM October 21st 2020, 10:10am |
|
@AmericanBanking Halozyme Therapeutics Target of Unusually Large Options Trading $HALO https://t.co/nPBh6mFpRL #stocks October 21st 2020, 9:10am |
|
@TranscriptDaily Halozyme Therapeutics Target of Unusually Large Options Trading $HALO https://t.co/EuEerAJ6sZ October 21st 2020, 9:10am |
 |
@SwingTradeBot $HALO technical alerts: New 52 Week High, New Uptrend, Expansion Breakout, Pocket Pivot, New 52 W... https://t.co/4mJYvrWbOw October 21st 2020, 8:10am |
 |
@HaloMeetup #darkmode ? how these icons pop! We are getting excited for #beta next month! #halo $HALO https://t.co/IfqbnU0xkM October 20th 2020, 9:10pm |
|
@gcassidy718 $HALO might hit $32.41 soon 2.43 % change recently. https://t.co/HafkoOqNbV October 20th 2020, 7:10pm |
|
@mediasentiment $HALO new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 2061 October 20th 2020, 5:10pm |
|
@WeekHerald Halozyme Therapeutics, Inc. $HALO SVP Sells $365,160.00 in Stock https://t.co/jKkbY9buCd October 20th 2020, 5:10pm |
|
@AmericanBanking Halozyme Therapeutics, Inc. $HALO SVP Sells $365,160.00 in Stock https://t.co/Yv3fuwza52 #stocks October 20th 2020, 5:10pm |
 |
@InsiderAlerts4U $HALO: New Insider Filing on HALOZYME THERAPEUTICS, INC.'s SVP, Chief Technical Officer MICHAEL J. LABARRE: https://t.co/oKSNkNVzr4 October 20th 2020, 5:10pm |
 |
@MonitorAction $HALO Michael Labarre Dumps 12K Shares of HALOZYME THERAPEUTICS, INC. https://t.co/eswVNIWdZD October 20th 2020, 5:10pm |
 |
@fintel_io Insider LaBarre Michael J. reports selling 12,000 shares of $HALO for a total cost of $365,148.00 https://t.co/bVBAGrOLG8 October 20th 2020, 4:10pm |
|
@Allstocknews $HALO Halozyme - 4 (Statement of Changes in Beneficial Ownership) SEC Filing From our Stock News Alerts App October 20th 2020, 4:10pm |
 |
@formwhisperscom #FWSells $HALO LaBarre Michael J., SVP, Chief Technical Officer of HALOZYME THERAPEUTICS, INC. sold 12,000 shares o… https://t.co/ZEonV9Lmqc October 20th 2020, 4:10pm |
 |
@LizabethBarham RT @AlfCharts: $HALO breaking out of a 3-month consolidation to new highs. https://t.co/bkWuCAensz October 20th 2020, 4:10pm |
 |
@AlertTrade Trading Ideas: $HALO, Bio Breakout https://t.co/iGUj251MJG ? FREE trade-of-week via ? https://t.co/BCEHq7TPrn https://t.co/u3DbgtnNfJ October 20th 2020, 4:10pm |
 |
@GSRTrades $HALO, yet another #biotech #breakout - Latest quarter showed a +290% earnings improvement. This #biopharma has a $… https://t.co/7J0eBPsYDl October 20th 2020, 4:10pm |
 |
@schaeffers Biotech stock $halo hit a record high today Our signal says it still has room to run https://t.co/2vqlDE9grO October 20th 2020, 4:10pm |
 |
@AlfCharts $HALO breaking out of a 3-month consolidation to new highs. https://t.co/bkWuCAensz October 20th 2020, 3:10pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2020. All rights reserved.
Get the DrugPatentWatch Daily Briefing
Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …
- ✓ Patent Expirations and Generic Entry
- ✓ 505(b)(2) & Biosimilars
- ✓ Insightful Articles and Case Studies
- ✓ Patent Litigation & Challenges
- ✓ Industry Trends
